Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06670040 · ClinicalTrials.gov registry record · NA
Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder
A NA study of Autism Spectrum Disorder and Autism, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06670040: Active NA study of Autism Spectrum Disorder and Autism, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT06670040 is a NA study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 24 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06670040, a NA study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the efficacy of accelerated theta burst stimulation (aTBS) in reducing depressive symptoms in autism spectrum disorder (ASD)
Primary Outcome
The HDRS is a 17-item rating scale administered by a trained rater following a semi-structured interview. Scores of 0-7 are generally within the normal range, and a score of 20 or higher indicates moderate depression severity. Research suggests that a decrement of 7 points on the HAMD-17 represents minimally clinically important differences from patient perspectives. HDRS will be assessed at screening, baseline and all follow up visits.
Conditions Studied
Interventions
- PROCEDURE Transcranial Magnetic Stimulation
- PROCEDURE Transcranial Magnetic Stimulation Sham
Study Locations (1)
Ohio
- Cincinnati Childrens Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT06670040 still lists
NCT06670040 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (82% lower).
The record links to 5 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.
NCT06670040 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06670040 about?
NCT06670040 is a clinical study titled "Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder". Evaluate the efficacy of accelerated theta burst stimulation (aTBS) in reducing depressive symptoms in autism spectrum disorder (ASD)
What is the current status of trial NCT06670040?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-09-16. Estimated completion is 2026-04-30.
What conditions does trial NCT06670040 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Depression - Major Depressive Disorder, MDD, ASD.
What interventions are being tested in trial NCT06670040?
The interventions under investigation include: Transcranial Magnetic Stimulation (PROCEDURE), Transcranial Magnetic Stimulation Sham (PROCEDURE).
Who is sponsoring clinical trial NCT06670040?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06670040 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06670040's enrollment target sits among peer trials
24 188th of 224 higher than 31 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI